Xiaobin Mei

802 total citations
22 papers, 635 citations indexed

About

Xiaobin Mei is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Xiaobin Mei has authored 22 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Physiology. Recurrent topics in Xiaobin Mei's work include Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Xiaobin Mei is often cited by papers focused on Inflammasome and immune disorders (5 papers), IL-33, ST2, and ILC Pathways (3 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Xiaobin Mei collaborates with scholars based in China, United States and Singapore. Xiaobin Mei's co-authors include Jiajun Fan, Dianwen Ju, Jingyun Luan, Xuyao Zhang, Wei Chen, Qi Bian, Tao Ding, Shaofei Wang, Yilan Shen and Yubin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Applied Microbiology and Biotechnology.

In The Last Decade

Xiaobin Mei

21 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobin Mei China 12 278 152 120 81 64 22 635
Qi Bian China 13 322 1.2× 122 0.8× 223 1.9× 76 0.9× 66 1.0× 25 681
Jia Guo China 14 233 0.8× 55 0.4× 115 1.0× 71 0.9× 60 0.9× 38 591
Yuebo Huang China 12 315 1.1× 87 0.6× 123 1.0× 60 0.7× 44 0.7× 14 587
Yin Li China 15 245 0.9× 69 0.5× 115 1.0× 83 1.0× 63 1.0× 27 611
Lanfeng Wang China 15 385 1.4× 70 0.5× 63 0.5× 122 1.5× 107 1.7× 25 778
Baoping Chen China 10 262 0.9× 61 0.4× 84 0.7× 49 0.6× 51 0.8× 19 469
Zijing Zhu China 18 402 1.4× 78 0.5× 229 1.9× 114 1.4× 83 1.3× 45 789
Yunxia Du China 13 365 1.3× 110 0.7× 122 1.0× 74 0.9× 49 0.8× 30 601
Chongxiu Yue China 6 553 2.0× 101 0.7× 85 0.7× 51 0.6× 58 0.9× 7 1.0k
Huabin Ma China 13 502 1.8× 140 0.9× 187 1.6× 97 1.2× 45 0.7× 26 849

Countries citing papers authored by Xiaobin Mei

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Mei more than expected).

Fields of papers citing papers by Xiaobin Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Mei. The network helps show where Xiaobin Mei may publish in the future.

Co-authorship network of co-authors of Xiaobin Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Mei. A scholar is included among the top collaborators of Xiaobin Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Mei. Xiaobin Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Xiaobin, et al.. (2024). Risk factors for rapid kidney function decline in diabetes patients. Renal Failure. 46(2). 2398188–2398188. 1 indexed citations
2.
Cao, Zhonglian, Hui Zhao, Jiajun Fan, et al.. (2023). Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. Cell Death Discovery. 9(1). 8–8. 16 indexed citations
3.
Shen, Yilan, Yuqing Xu, Pei Kang Shen, et al.. (2023). A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation. Applied Microbiology and Biotechnology. 107(7-8). 2561–2576. 4 indexed citations
4.
Chen, Si, Xiaoyan Ma, Xun Zhou, et al.. (2022). An updated clinical prediction model of protein-energy wasting for hemodialysis patients. Frontiers in Nutrition. 9. 933745–933745. 2 indexed citations
5.
Gu, Yuting, Yilan Shen, Wei Chen, et al.. (2022). Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response. Applied Microbiology and Biotechnology. 106(7). 2637–2649. 7 indexed citations
6.
Han, Lei, Chenchen Shi, Xian Zeng, et al.. (2021). A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus. Frontiers in Immunology. 12. 727941–727941. 8 indexed citations
7.
Chen, Wei, Yilan Shen, Jiajun Fan, et al.. (2021). IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury. SHILAP Revista de lepidopterología. 11(2). e324–e324. 28 indexed citations
8.
Shen, Yilan, Xin Jin, Wei Chen, et al.. (2020). Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses. Applied Microbiology and Biotechnology. 104(13). 5889–5898. 27 indexed citations
9.
Shen, Yilan, Wei Chen, Lei Han, et al.. (2020). VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses. Acta Pharmaceutica Sinica B. 11(1). 127–142. 44 indexed citations
10.
Zai, Wenjing, Wei Chen, Zimei Wu, et al.. (2019). Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease. ACS Applied Materials & Interfaces. 11(5). 4842–4857. 48 indexed citations
11.
Zhang, Xuyao, Yichen Wang, Jiajun Fan, et al.. (2019). Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 7(1). 346–346. 82 indexed citations
12.
Wang, Shaofei, Jiajun Fan, Xiaobin Mei, et al.. (2019). Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome. Frontiers in Immunology. 10. 2277–2277. 23 indexed citations
13.
Ding, Tao, Shaofei Wang, Xuyao Zhang, et al.. (2018). Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome. Phytomedicine. 41. 45–53. 160 indexed citations
14.
Wang, Shaofei, Yubin Li, Jiajun Fan, et al.. (2017). Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation. Cell Death and Disease. 8(7). e2937–e2937. 85 indexed citations
15.
Li, Yubin, Xian Zeng, Shaofei Wang, et al.. (2015). Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase. Tumor Biology. 37(5). 6627–6635. 19 indexed citations
16.
Fan, Jiajun, Xian Zeng, Yubin Li, et al.. (2015). A novel therapeutic approach against B-cell non-Hodgkin’s lymphoma through co-inhibition of Hedgehog signaling pathway and autophagy. Tumor Biology. 37(6). 7305–7314. 10 indexed citations
17.
Ding, Jiarong, Chao Zhu, Xiaobin Mei, et al.. (2015). Peroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.. PubMed. 8(5). 7655–60. 4 indexed citations
18.
Liu, Feng, Xiaobin Mei, Yingying Zhang, et al.. (2014). Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients. Molecular Biology Reports. 41(11). 7555–7565. 9 indexed citations
19.
Shen, Fei & Xiaobin Mei. (2011). Concomitant kidney diseases of ichthyosis. Pharmaceutical Care and Research. 11(3). 227–229.
20.
Mei, Xiaobin. (2004). Role of cyclin kinase inhibitor p27 in inhibition of emodin on mesangial cell proliferation induced by tumor necrosis factor-α. Journal of Chinese Integrative Medicine. 2(2). 120–122. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Bian Breakdown of academic impact, for papers by Jia Guo Breakdown of academic impact, for papers by Yuebo Huang Breakdown of academic impact, for papers by Yin Li Breakdown of academic impact, for papers by Lanfeng Wang Breakdown of academic impact, for papers by Baoping Chen Breakdown of academic impact, for papers by Zijing Zhu Breakdown of academic impact, for papers by Yunxia Du Breakdown of academic impact, for papers by Chongxiu Yue Breakdown of academic impact, for papers by Huabin Ma
Rankless by CCL
2026